FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma
The U.S. Food and Drug Administration has approved a new first-line treatment for people with pleural mesothelioma that can’t be removed with surgery. This new approval is specifically for a Keytruda (pembrolizumab) plus pemetrexed and platinum chemotherapy combination. The FDA’s approval follows promising results in phases 2 and 3 of the Keynote-483 trial. This clinical […]
The post FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.